Drug-Eluting Balloons Are Promising for Claudicants

In a blog post on the VDM clinical blog this month, editor in chief Frank J. Criado, MD, FACS, FSVM, described recent data published in the Journal of the American College of Cardiology in March on paclitaxel-eluting balloons (PEBs). The study was a non-industry sponsored independent, prospective, multicenter registry that aimed to assess clinical outcomes of femoropopliteal angioplasty with the In.Pact Admiral PEB by Medtronic, and results indicated that the treatment could be a viable option for patients with claudication.

Read “Drug-Eluting Balloon Angioplasty in the Femoropopliteal Segment: Appealing Option for Claudicants” by Dr. Criado for more information on this study.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s